In a significant breakthrough for the development of supercritical carbon dioxide (sCO 2) power cycles, the 10-MWe Supercritical Transformational Electric Power (STEP) Demo pilot plant in San Antonio, ...
Vigil Neuroscience reported positive Phase 1 trial results for VG-3927 and plans a Phase 2 trial in Q3 2025. Vigil Neuroscience, Inc. announced promising outcomes from a Phase 1 clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback